MoneyWorks4Me

The revenue zoomed 10.91% to Rs. 5803.90 millions for the quarter ended December 2025 as compared to Rs. 5233.00 millions during the corresponding quarter last year.Profit for the quarter ended December 2025 increased merely by0.15% to Rs. 205.80  millions from Rs. 205.50 millions.Operating profit for the quarter ended December 2025 rose to 625.60 millions as compared to 509.40 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 5803.90 5233.00 10.91 16996.10 15514.30 9.55 20792.10 21327.90 -2.51
Other Income 52.90 40.70 29.98 195.40 178.80 9.28 224.00 300.70 -25.51
PBIDT 625.60 509.40 22.81 1960.60 1571.10 24.79 2245.70 2615.90 -14.15
Interest 36.30 44.60 -18.61 113.40 107.30 5.68 147.60 161.00 -8.32
PBDT 477.20 464.80 2.67 1735.10 1463.80 18.53 2098.10 2454.90 -14.53
Depreciation 201.70 186.60 8.09 599.00 533.90 12.19 719.20 628.50 14.43
PBT 275.50 278.20 -0.97 1136.10 929.90 22.17 1378.90 1826.40 -24.50
TAX 69.70 72.70 -4.13 290.70 236.10 23.13 368.90 472.20 -21.88
Deferred Tax 9.90 29.30 -66.21 36.40 59.30 -38.62 121.50 102.10 19.00
PAT 205.80 205.50 0.15 845.40 693.80 21.85 1010.00 1354.20 -25.42
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 10.78 9.73 10.73 11.54 10.13 13.91 10.80 12.27 -11.94
Peers
Company Name CMP
Sun Pharma. Inds. 1846.40
Dr. Reddys Labs. 1143.95
Cipla 1374.70
Lupin 2081.40
Zydus Lifesciences 1115.85
View more..